title: Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection.
abstract: TT virus (TTV) is a recently identified widespread DNA virus of humans that produces persistent viremia in the absence of overt clinical manifestations. In an attempt to shed light on the dynamics of chronic infection, we measured the levels of TTV in the plasma of 25 persistently infected patients during the first 3 months of alpha interferon (IFN-alpha) treatment for concomitant hepatitis C virus (HCV) infection. The first significant decline of TTV loads was observed at day 3 versus day 1 for HCV. Subsequently, the loads of TTV became progressively lower in most patients, but some initial responders relapsed before the end of the follow-up, suggesting that at least in some subjects the effects of IFN on TTV can be very short-lived. No correlation between the responses of TTV and HCV to therapy was found. Fitting the viremia data obtained during the first week of treatment into previously developed mathematical models showed that TTV sustains very active chronic infections, with over 90% of the virions in plasma cleared and replenished daily and a minimum of approximately 3.8 x 10(10) virions generated per day. Low levels of TTV were occasionally detected in the peripheral blood mononuclear cells of patients who had cleared plasma viremia, thus corroborating previous results showing that these cells may support TTV replication and/or persistence.
authors.affiliation: Virology Section and Retrovirus Center, Department of Biomedicine, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Maggi
authors.forename: M
authors.initials: M
authors.lastname: Pistello
authors.forename: M
authors.initials: M
authors.lastname: Vatteroni
authors.forename: S
authors.initials: S
authors.lastname: Presciuttini
authors.forename: S
authors.initials: S
authors.lastname: Marchi
authors.forename: P
authors.initials: P
authors.lastname: Isola
authors.forename: C
authors.initials: C
authors.lastname: Fornai
authors.forename: S
authors.initials: S
authors.lastname: Fagnani
authors.forename: E
authors.initials: E
authors.lastname: Andreoli
authors.forename: G
authors.initials: G
authors.lastname: Antonelli
authors.forename: M
authors.initials: M
authors.lastname: Bendinelli
mesh_terms: D000328:Adult; D002908:Chronic Disease; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D022783:Torque teno virus / Q000302:isolation & purification* / Q000502:physiology; D019562:Viral Load; D014766:Viremia / Q000821:virology; D014779:Virus Replication
chemical_list: D016898:Interferon-alpha